Exelixis (EXEL) EBT (QoQ) (2010 - 2026)
Exelixis (EXEL) EBT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Exelixis | 14.50 Bn | 13.72 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 5.94% |
| Jan 2, 2026 | 0.11% |
| Oct 3, 2025 | 9.55% |
| Jul 4, 2025 | 12.02% |
| Apr 4, 2025 | 11.32% |
| Jan 3, 2025 | 19.40% |
| Sep 27, 2024 | -47.15% |
| Jun 28, 2024 | 494.40% |
| Mar 29, 2024 | -52.19% |
| Dec 29, 2023 | 1,671.04% |
| Sep 29, 2023 | -94.20% |
| Jun 30, 2023 | 107.93% |
| Mar 31, 2023 | 253.62% |
| Dec 30, 2022 | -134.14% |
| Sep 30, 2022 | 3.99% |
| Jul 1, 2022 | 3.85% |
| Apr 1, 2022 | -27.78% |
| Dec 31, 2021 | 121.59% |
| Oct 1, 2021 | -57.35% |
| Jul 2, 2021 | 6,297.92% |